AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Total cash & short-term investments

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥9.22T
P/E ratio
59.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 2025405,589-14.23%
Mar 31, 2024472,889-14.60%
Mar 31, 2023553,704-36.72%
Mar 31, 2022875,000-12.75%
Mar 31, 20211,002,820+53.47%
Mar 31, 2020653,436-9.92%
Mar 31, 2019725,369+184.41%
Mar 31, 2018255,041+187.05%
Mar 31, 201788,850-63.30%
Mar 31, 2016242,072-23.20%
Mar 31, 2015315,200

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)